• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Sun Pharma > August 10, 2005

      Sun Pharma Buys Stake in Hungary Co.

      Posted AtFinancial Express

      MUMBAI, AUGUST 10 : Indian drug maker Sun Pharmaceutical Industries Ltd. said on Wednesday it had acquired a stake in ICN Company Hungary Ltd. from Valeant Pharmaceuticals International.The purchase of the raw materials and dosage form manufacturing operations in Hungary gave Sun an early opportunity to enter the European generic market, its chairman Dilip Shanghvi said in a statement.

      The terms of the deal were not disclosed.

      Valeant said in a statement posted on its Web site that it had reported the sold operations as discontinued operations earlier.

      "The sale of Hungary represents the final piece of our planned divestiture of non-core operations," Timothy Tyson, Valeant's chief executive officer, said.

      He said the divestiture of the company's remaining manufacturing facilities continued to advance and that Valeant was confident it would reduce its network to 4 manufacturing sites by the end of 2006.

      Shares of Sun, India's second-largest pharmaceutical company by market value, rose 2.5 percent to 615 rupees in the afternoon.

      ($1 = 43.5 Indian rupees)

      August 10, 2005


      Share this Article!

    Back to top^